One writer shares her own unexpected pregnancy while taking the tirzepatide shot, and says many others have been through the same thing.
Recap by typeshit. Full story at The Times.
Researchers looked at U.S. adults with type 2 diabetes starting a GLP-1 and estimate a small added risk of sudden vision loss that is often permanent.
Avi Roy says a Chinese supplier shipped retatrutide with a purity certificate, but a buyer's own germ test came back failed. A sharp look at gray-market risks.
10:44
A personal account of a month on retatrutide, a drug still in trials and not approved for sale. It amounts to one person's anecdote, with no sourcing given.
An unsourced alert says compounded injectables, sermorelin included, face scrutiny over sterility. It names no regulator or official action.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
A short Philstar Life item on PIONEER 8, a trial of oral semaglutide. The material gives only the title, so tap through for the details.
Loading…